CATALOGO DEI PRODOTTI DELLA RICERCA

VIAPIANA, Ombretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.631
NA - Nord America 6.732
AS - Asia 2.674
SA - Sud America 33
OC - Oceania 14
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 17.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.698
GB - Regno Unito 2.771
CN - Cina 1.998
IT - Italia 1.204
SE - Svezia 685
DE - Germania 660
IE - Irlanda 593
FR - Francia 587
RU - Federazione Russa 474
SG - Singapore 361
FI - Finlandia 344
UA - Ucraina 129
JP - Giappone 99
TR - Turchia 82
VN - Vietnam 51
BE - Belgio 42
CA - Canada 32
AT - Austria 24
NL - Olanda 24
KR - Corea 22
ES - Italia 20
IN - India 18
RO - Romania 18
BR - Brasile 16
IR - Iran 15
AU - Australia 11
CH - Svizzera 8
CL - Cile 7
PL - Polonia 7
QA - Qatar 5
ZA - Sudafrica 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
EU - Europa 4
HK - Hong Kong 4
HU - Ungheria 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TH - Thailandia 3
AR - Argentina 2
BD - Bangladesh 2
BG - Bulgaria 2
EC - Ecuador 2
ID - Indonesia 2
IL - Israele 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
SI - Slovenia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SM - San Marino 1
Totale 17.103
Salva come PNG Salva come JPEG
Città #
Southend 2.632
Chandler 1.335
Jacksonville 883
Dublin 590
Ann Arbor 475
Woodbridge 465
Ashburn 393
Beijing 359
Houston 282
Singapore 235
Lawrence 234
Princeton 234
Wilmington 231
Jinan 221
Redmond 194
Bologna 184
Shenyang 172
Nanjing 170
New York 168
Verona 148
Helsinki 106
Hebei 104
Sindelfingen 85
Tokyo 85
Tianjin 83
Milan 82
Changsha 72
Ningbo 68
Haikou 67
Zhengzhou 64
Nanchang 56
Taizhou 56
Redwood City 54
Jiaxing 48
Hangzhou 45
Taiyuan 44
Brussels 41
Seattle 41
Guangzhou 36
Norwalk 35
Boardman 34
Washington 34
Fuzhou 29
Düsseldorf 27
Fairfield 27
Lanzhou 26
Dong Ket 25
Falls Church 23
Vienna 23
Dearborn 22
Torino 22
Lancaster 21
Rome 21
San Francisco 21
Los Angeles 20
Dallas 19
Detroit 18
Nürnberg 16
Sanayi 16
Venice 16
Orani 15
Seoul 15
Toronto 15
Cagliari 13
Chicago 13
Dongguan 13
Kent 13
Turin 13
Florence 11
Kemerovo 10
Boydton 9
Amsterdam 8
Esslingen am Neckar 8
Florianópolis 8
Padova 8
Bari 7
Bârlad 7
Moscow 7
Naples 7
Palermo 7
Saint Louis 7
Brescia 6
Chiampo 6
Clearwater 6
Denver 6
Lappeenranta 6
Montréal 6
Ottawa 6
Ragusa 6
Seo-gu 6
Shanghai 6
Ardabil 5
Auburn Hills 5
Berlin 5
Easton 5
Falkenstein 5
Grosseto 5
Leawood 5
Miami 5
Novokuznetsk 5
Totale 11.656
Salva come PNG Salva come JPEG
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 526
Teriparatide and denosumab combination therapy and skeletal metabolism 243
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 169
Artrite Reumatoide e Metabolismo Minerale 164
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 146
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 134
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 128
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 127
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 122
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 118
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 114
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 114
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 113
DXA bone mineral density in males: retrospective study in real life. 111
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 110
Prevalence and incidence of rheumatoid arthritis in Italy. 110
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 110
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 109
Bone metabolism in patients with anorexia nervosa and amenorrhoea 109
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 107
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 106
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 105
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 102
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 102
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 102
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 101
Osteopetrosi 101
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 101
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 100
Guidelines for the diagnosis, prevention and management of osteoporosis 100
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 99
Anti-CCP antibodies and bone 99
Prevalence of osteoporosis in patients affected by mastocytosis 98
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 98
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 97
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 97
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 95
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 95
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 95
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 95
Safety issues and adverse reactions with osteoporosis management 94
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 94
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 94
Bone turnover markers in patients with osteogenesis imperfecta 92
Bone turnover markers in patients with osteogenesis imperfecta. 92
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 92
Could γ\δ T-cells explain zoledronic acid adverse events? 92
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 90
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 89
Bone involvement and osteoporosis in mastocytosis. 88
Drug-induced osteonecrosis of the jaw: the state of the art 87
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 86
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 86
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 86
Duration of treatment for osteoporosis 86
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 85
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 85
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 85
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 84
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 84
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 84
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 84
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 83
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 83
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 83
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 83
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 83
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 83
Effects of denosumab on peripheral lymphocyte subpopulations 83
Osteoporosi ed attività sportiva. 82
Sclerostin and DKK1 in primary hyperparathyroidism. 82
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 82
[Risk factors for hip fracture in elderly persons]. 82
Variazione della densità minerale ossea ed attività antifratturativa; 82
IBANDRONATE: NEW OPTIONS IN THE TREATMENT OF OSTEOPOROSIS 81
Rheumatoid arthritis, γδ T cells and bisphosphonates 80
Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis 80
Osteoporosi ed attività sportiva: 79
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 79
Vitamin D and rheumatic diseases. 79
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 79
Interferential and horizontal therapies in chronic low back pain: a randomized, double blind, clinical study. 79
Instrumental diagnosis of osteoporosis. 78
Intravenous bisphosphonate therapy increases radial width in adults with Osteogenesis Imperfecta. 78
Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. 78
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 78
Instrumental diagnosis of osteoporosis 77
Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients. 77
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 77
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 77
bone anabolic agents: the unansweres queries: 76
Osteoporosi 76
Ruolo della vitamina D 75
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. 75
Neridronic acid for the treatment of bone metabolic diseases 75
[Pathophysiology of osteoarthritis: perspectives] 75
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 75
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 75
The obesity paradox and osteoporosis 75
Totale 9.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.296
article - articoli 58.437
book - libri 0
conference - conferenze 325
curatela - curatele 0
other - altro 778
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.756
Totale 122.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.668 0 0 32 188 226 219 206 142 142 155 101 257
2020/20212.240 287 407 80 300 306 207 74 96 165 15 202 101
2021/20221.908 127 520 29 110 88 55 59 107 145 48 143 477
2022/20234.026 282 380 382 709 332 966 51 224 461 59 129 51
2023/20242.170 111 163 193 264 238 344 103 171 28 92 318 145
2024/2025649 286 344 19 0 0 0 0 0 0 0 0 0
Totale 17.555